Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/45540 |
Resumo: | Objective: To systematically review the evidence on the use of melatonin in the treatment of sleep disorders in children and adolescents with autism spectrum disorder (ASD). Method: Systematic review of randomized controlled clinical trials on the use of melatonin and included children and adolescents with ASD and sleep disorders, searching MEDLINE, SCOPUS, Web of science, Cochrane Central Register Controlled Trials, in the period between September and October 2023. The selection of studies were carried out using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results: Changes in Total Sleep Time (TST) and Sleep Latency (SL) measurements were statistically significant. The 95% CI of 1.66 [1.10, 2.23] and 2.55 [1.02, 4.08] showed an increase in TST with the use of the intervention. (p < 0.00001) [18, 19]. Garstang showed a statistical difference with the use of melatonin, with the result of 95% CI of -5.96 [-8.77, -3.16], as well as Cortesi with a 95% CI of -1.23 [-1.75, - 0.70] and Gringras with -1.35 [-1.79, -0.91], with reduced latency to start sleep (p = 0.0002). Conclusions: Larger samples are needed to evaluate the effectiveness of melatonin on other sleep patterns, such as nighttime awakenings and sleep quality. |
id |
UNIFEI_1f99b82a78e60a1b4da0570a2e5953fe |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/45540 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisisMelatonina versus placebo no tratamento de distúrbios do sono em crianças e adolescentes com autismo: Revisão sistemática com meta-análiseMelatonin versus placebo in the treatment of sleep disorders in children and adolescents with autism: Systematic review and meta-analysisInsomnioNiñosMelatoninaDesorden del espectro autistaEnsayo clínico.InsôniaCriançasMelatoninaTranstorno do espectro do autismoEnsaios clínicos.InsomniaChildrenMelatoninAutism spectrum disorderClinical trial.Objective: To systematically review the evidence on the use of melatonin in the treatment of sleep disorders in children and adolescents with autism spectrum disorder (ASD). Method: Systematic review of randomized controlled clinical trials on the use of melatonin and included children and adolescents with ASD and sleep disorders, searching MEDLINE, SCOPUS, Web of science, Cochrane Central Register Controlled Trials, in the period between September and October 2023. The selection of studies were carried out using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results: Changes in Total Sleep Time (TST) and Sleep Latency (SL) measurements were statistically significant. The 95% CI of 1.66 [1.10, 2.23] and 2.55 [1.02, 4.08] showed an increase in TST with the use of the intervention. (p < 0.00001) [18, 19]. Garstang showed a statistical difference with the use of melatonin, with the result of 95% CI of -5.96 [-8.77, -3.16], as well as Cortesi with a 95% CI of -1.23 [-1.75, - 0.70] and Gringras with -1.35 [-1.79, -0.91], with reduced latency to start sleep (p = 0.0002). Conclusions: Larger samples are needed to evaluate the effectiveness of melatonin on other sleep patterns, such as nighttime awakenings and sleep quality.Objetivo: Revisar sistemáticamente la evidencia sobre el uso de melatonina en el tratamiento de los trastornos del sueño en niños y adolescentes con trastorno del espectro autista (TEA). Método: Revisión sistemática de ensayos clínicos controlados aleatorios sobre el uso de melatonina e incluyeron niños y adolescentes con TEA y trastornos del sueño, buscando en MEDLINE, SCOPUS, Web of science, Cochrane Central Register Controlled Trials, en el período comprendido entre septiembre y octubre de 2023. La selección de estudios se llevó a cabo utilizando los elementos de informes preferidos para revisiones sistemáticas y metanálisis (PRISMA). Resultados: Los cambios en las mediciones del tiempo total de sueño (TST) y la latencia del sueño (SL) fueron estadísticamente significativos. El IC del 95% de 1,66 [1,10, 2,23] y 2,55 [1,02, 4,08] mostró un aumento en la TST con el uso de la intervención. (p <0,00001) [18, 19]. Garstang mostró diferencia estadística con el uso de melatonina, con el resultado de IC 95% de -5.96 [-8.77, -3.16], así como Cortesi con un IC 95% de -1.23 [-1.75, - 0.70] y Gringras con -1,35 [-1,79, -0,91], con latencia reducida para iniciar el sueño (p = 0,0002). Conclusiones: Se necesitan muestras más amplias para evaluar la eficacia de la melatonina sobre otros patrones de sueño, como los despertares nocturnos y la calidad del sueño.Objetivo: Revisar sistematicamente as evidências sobre o uso da melatonina no tratamento de distúrbios do sono em crianças e adolescentes com transtorno do espectro do autismo (TEA). Método: Revisão sistemática de ensaios clínicos randomizados controlados sobre o uso de melatonina e incluídos crianças e adolescentes com TEA e distúrbios do sono, pesquisando MEDLINE, SCOPUS, Web of science, Cochrane Central Register Controlled Trials, no período entre setembro e outubro de 2023. O a seleção dos estudos foi realizada por meio do Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Resultados: As alterações nas medidas do Tempo Total de Sono (TTS) e da Latência do Sono (SL) foram estatisticamente significativas. O IC 95% de 1,66 [1,10; 2,23] e 2,55 [1,02; 4,08] mostrou aumento do PT com o uso da intervenção. (p < 0,00001) [18, 19]. Garstang apresentou diferença estatística com o uso de melatonina, com resultado de IC 95% de -5,96 [-8,77, -3,16], assim como Cortesi com IC 95% de -1,23 [-1,75, -0,70] e Gringras com -1,35 [-1,79, -0,91], com latência reduzida para iniciar o sono (p = 0,0002). Conclusões: São necessárias amostras maiores para avaliar a eficácia da melatonina em outros padrões de sono, como despertares noturnos e qualidade do sono.Research, Society and Development2024-04-16info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4554010.33448/rsd-v13i4.45540Research, Society and Development; Vol. 13 No. 4; e6213445540Research, Society and Development; Vol. 13 Núm. 4; e6213445540Research, Society and Development; v. 13 n. 4; e62134455402525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/45540/36280Copyright (c) 2024 Juliana Santos Feitosa; Natália Araújo Barreto; Talita Santos Andrade; Glauber Amaral de Oliveira; Larissa Marrocos de Oliveira; Tarcisio Brandão Limahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFeitosa, Juliana Santos Barreto, Natália Araújo Andrade, Talita Santos Oliveira, Glauber Amaral de Oliveira, Larissa Marrocos de Lima, Tarcisio Brandão 2024-04-04T18:36:37Zoai:ojs.pkp.sfu.ca:article/45540Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-04-04T18:36:37Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisis Melatonina versus placebo no tratamento de distúrbios do sono em crianças e adolescentes com autismo: Revisão sistemática com meta-análise Melatonin versus placebo in the treatment of sleep disorders in children and adolescents with autism: Systematic review and meta-analysis |
title |
Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisis |
spellingShingle |
Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisis Feitosa, Juliana Santos Insomnio Niños Melatonina Desorden del espectro autista Ensayo clínico. Insônia Crianças Melatonina Transtorno do espectro do autismo Ensaios clínicos. Insomnia Children Melatonin Autism spectrum disorder Clinical trial. |
title_short |
Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisis |
title_full |
Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisis |
title_fullStr |
Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisis |
title_full_unstemmed |
Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisis |
title_sort |
Melatonina versus placebo en el tratamiento de los trastornos del sueño en niños y adolescentes con autismo: Revisión sistemática y metanálisis |
author |
Feitosa, Juliana Santos |
author_facet |
Feitosa, Juliana Santos Barreto, Natália Araújo Andrade, Talita Santos Oliveira, Glauber Amaral de Oliveira, Larissa Marrocos de Lima, Tarcisio Brandão |
author_role |
author |
author2 |
Barreto, Natália Araújo Andrade, Talita Santos Oliveira, Glauber Amaral de Oliveira, Larissa Marrocos de Lima, Tarcisio Brandão |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Feitosa, Juliana Santos Barreto, Natália Araújo Andrade, Talita Santos Oliveira, Glauber Amaral de Oliveira, Larissa Marrocos de Lima, Tarcisio Brandão |
dc.subject.por.fl_str_mv |
Insomnio Niños Melatonina Desorden del espectro autista Ensayo clínico. Insônia Crianças Melatonina Transtorno do espectro do autismo Ensaios clínicos. Insomnia Children Melatonin Autism spectrum disorder Clinical trial. |
topic |
Insomnio Niños Melatonina Desorden del espectro autista Ensayo clínico. Insônia Crianças Melatonina Transtorno do espectro do autismo Ensaios clínicos. Insomnia Children Melatonin Autism spectrum disorder Clinical trial. |
description |
Objective: To systematically review the evidence on the use of melatonin in the treatment of sleep disorders in children and adolescents with autism spectrum disorder (ASD). Method: Systematic review of randomized controlled clinical trials on the use of melatonin and included children and adolescents with ASD and sleep disorders, searching MEDLINE, SCOPUS, Web of science, Cochrane Central Register Controlled Trials, in the period between September and October 2023. The selection of studies were carried out using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results: Changes in Total Sleep Time (TST) and Sleep Latency (SL) measurements were statistically significant. The 95% CI of 1.66 [1.10, 2.23] and 2.55 [1.02, 4.08] showed an increase in TST with the use of the intervention. (p < 0.00001) [18, 19]. Garstang showed a statistical difference with the use of melatonin, with the result of 95% CI of -5.96 [-8.77, -3.16], as well as Cortesi with a 95% CI of -1.23 [-1.75, - 0.70] and Gringras with -1.35 [-1.79, -0.91], with reduced latency to start sleep (p = 0.0002). Conclusions: Larger samples are needed to evaluate the effectiveness of melatonin on other sleep patterns, such as nighttime awakenings and sleep quality. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-04-16 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/45540 10.33448/rsd-v13i4.45540 |
url |
https://rsdjournal.org/index.php/rsd/article/view/45540 |
identifier_str_mv |
10.33448/rsd-v13i4.45540 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/45540/36280 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 13 No. 4; e6213445540 Research, Society and Development; Vol. 13 Núm. 4; e6213445540 Research, Society and Development; v. 13 n. 4; e6213445540 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052639866781696 |